GlassScriptPhysician profile
Jill Koeppen
NPI 1427042027
$8,955.57
in general payments reported to CMS, 2019-2025
45 companies · $1,899 in 2025
The $1,899 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,402 · 2022: $1,116 · 2023: $2,265 · 2024: $2,273 · 2025: $1,899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,257 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,256.98 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,827.81 | 2021-2025 | |
| Novo Nordisk INC | $866.56 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $781.55 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $734.24 | 2021-2025 | |
| Astellas Pharma US INC | $540.67 | 2023-2025 | Veozah |
| Amgen INC. | $481.80 | 2022-2025 | Prolia, Krystexxa, Evenity |
| Corium, LLC | $393.67 | 2022-2025 | Azstarys |
| Bausch Health US, LLC | $383.35 | 2022-2025 | Aplenzin, Wellbutrin |
| Boehringer Ingelheim Pharmaceuticals, INC. | $333.68 | 2021-2025 | Jardiance, Ofev |
| Astrazeneca Pharmaceuticals LP | $325.23 | 2022-2025 | Breztri, Farxiga |
| Lundbeck LLC | $324.79 | 2021-2025 | Rexulti, Vyepti |
| Exact Sciences Corporation | $271.19 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $205.34 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Biohaven Pharmaceuticals, INC. | $160.91 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $131.31 | 2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Koeppen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.